Tim Elliott Selected Research

Neoplasms (Cancer)

1/2023	Advancing our knowledge of antigen processing with computational modelling, structural biology, and immunology.
1/2023	Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1.
1/2022	Tapasin-mediated editing of the MHC I immunopeptidome is epitope specific and dependent on peptide off-rate, abundance, and level of tapasin expression.
1/2021	The immunopeptidomes of two transmissible cancers and their host have a common, dominant peptide motif.
10/2020	Time-resolved microwell cell-pairing array reveals multiple T cell activation profiles.
12/2019	Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
1/2019	HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC.
1/2018	The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer.
1/2018	A Mechanistic Model for Predicting Cell Surface Presentation of Competing Peptides by MHC Class I Molecules.
12/2015	Plasticity of empty major histocompatibility complex class I molecules determines peptide-selector function.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Elliott Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 11/2002
8	Infections 10/2023 - 06/2004
4	Skin Neoplasms (Skin Cancer) 08/2012 - 01/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2004
3	Crohn Disease (Crohn's Disease) 01/2020 - 10/2008
2	Orofacial Granulomatosis 01/2020 - 01/2011
2	Ankylosing Spondylitis 12/2014 - 02/2014
2	Melanoma (Melanoma, Malignant) 11/2011 - 01/2004
1	Alzheimer Disease (Alzheimer's Disease) 12/2022
1	Human Influenza (Influenza) 01/2022
1	Hypersensitivity (Allergy) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Dehydration (Water Stress) 10/2019
1	AIDS-Related Complex (ARC) 10/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Malaria 11/2018
1	Necrosis 01/2017
1	Disease Progression 10/2011
1	Virus Diseases (Viral Diseases) 10/2011
1	Fistula 10/2008
1	Carcinoma (Carcinomatosis) 04/2007
1	Testicular Neoplasms (Testicular Cancer) 01/2007
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Vaccinia 01/2006
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2004
1	Pain (Aches) 01/2004
1	Bowen's Disease (Disease, Bowen) 01/2004
1	Erythema 01/2004
1	Autoimmune Diseases (Autoimmune Disease) 11/2002

Drug/Important Bio-Agent (IBA)

13	Peptides (Polypeptides)IBA 01/2023 - 02/2008
7	Histocompatibility Antigens Class IIBA 01/2022 - 02/2008
6	VaccinesIBA 01/2023 - 06/2004
6	AntigensIBA 01/2023 - 11/2002
5	EpitopesIBA 01/2023 - 01/2019
2	InterferonsIBA 10/2023 - 01/2017
2	CytokinesIBA 10/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2015
2	tapasinIBA 01/2022 - 11/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 12/2019
2	Glycoproteins (Glycoprotein)IBA 12/2019 - 04/2007
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2019 - 11/2002
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 12/2014 - 02/2014
2	LigandsIBA 09/2012 - 02/2008
1	IsotopesIBA 12/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	Immunodominant EpitopesIBA 01/2022
1	PiperazineIBA 10/2021
1	FenbendazoleIBA 10/2021
1	Levamisole (Decaris)FDA Link 10/2021
1	abacavir (Ziagen)FDA Link 01/2021
1	HLA-B57 antigenIBA 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2020
1	serpentine (alkaloid)IBA 10/2019
1	Complement System Proteins (Complement)IBA 10/2019
1	MolybdenumIBA 10/2019
1	Histocompatibility Antigens Class IIIBA 11/2018
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 11/2018
1	AnthelminticsIBA 07/2017
1	AminopeptidasesIBA 02/2014
1	Arginine (L-Arginine)FDA Link 02/2014
1	leucinethiolIBA 06/2013
1	Viral AntigensIBA 09/2012
1	Neuraminidase (Sialidase)IBA 09/2012
1	SteroidsIBA 10/2008
1	Thioguanine (Tioguanine)FDA Link 10/2008
1	Infliximab (Remicade)FDA Link 10/2008
1	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2006
1	DNA VaccinesIBA 06/2004
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	AutoantigensIBA 11/2002

Therapy/Procedure

3	Mohs Surgery (Mohs' Micrographic Surgery) 08/2012 - 05/2011
2	Immunotherapy 01/2023 - 06/2013
2	Therapeutics 06/2013 - 01/2011
1	Lasers (Laser) 05/2011
1	Analgesia 01/2004
1	Photochemotherapy (Photodynamic Therapy) 01/2004
1	Aftercare (After-Treatment) 01/2004